05:08 PM EDT, 05/14/2024 (MT Newswires) -- Nuvation Bio ( NUVB ) reported a Q1 loss late Tuesday of $0.07 per diluted share, narrowing from the loss of $0.10 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.10.

The company didn't report revenue, as expected by analysts surveyed by Capital IQ.

As of March 31, the company had cash, cash equivalents and marketable securities of $597 million.

Nuvation Bio ( NUVB ) shares fell 7% in after-hours activity.

Price: 3.0700, Change: -0.23, Percent Change: -6.97